It was found that red koji rice could reduce LDL cholesterol and triglyceride levels

Cardiovascular disease is the main cause of death, and one of the main risk factors of the disease is dyslipidemia, especially hypercholesterolemia Recently, a study published in the Journal of lipid health (http:// and diseases showed that argicollina, a new dietary supplement brand launched by Italy's damor Pharmaceutical (http:// Company (http:// helped reduce the levels of LDL cholesterol and triglycerides The main ingredients of argicollina are Monascus purpureus, coenzyme Q10 and vitamin C In this study, the researchers observed that the brand has clinical significance in reducing blood lipid, while the level of triglyceride also decreased significantly In this study, researchers focused on the presence of Monacolin K in dietary supplement products (http:// a fungus produced during rice fermentation Monacolin K has been widely studied and published in several journals, and it has also been proved to reduce serum total cholesterol In the current study, researchers are trying to determine whether dietary supplements containing Monacolin K, essential amino acid L-arginine and coenzyme 10, an antioxidant often added to dietary supplement products with claims of heart health, can provide further lipid lowering benefits This is a single center, randomized, cross-over trial (http:// in which 19 subjects aged 18-75 were recruited, and their serum LDL cholesterol was 130-180 mg / dl The subjects were randomly given two supplements a day, including argicollina products or normolip 5 capsules, for a total of eight weeks, plus a four week washdown period In five visits, the researchers evaluated subjects' total cholesterol levels, HDL cholesterol levels, LDL cholesterol, triglycerides, and fasting blood glucose levels In addition, the researchers measured subjects' brachial artery pressure and heart rate during three, four, and five interviews The results showed that argicollina and normalip 5 significantly reduced LDL cholesterol levels in subjects, which were 25.6% and 23.3%, respectively Argicollina and normal IP 5 can reduce the total cholesterol of the subjects Although the treatment comparison between them is not significant, argicollina is more significant in reducing the total cholesterol Argicollina did not appear to have altered HDL cholesterol, while normalip 5 significantly increased HDL cholesterol In addition, argicollina significantly reduced triglyceride content compared to subjects who received normal IP 5 supplementation The researchers concluded that Monascus rice supplements reduce LDL cholesterol The researchers also pointed out that the effect of argicollina on reducing triglycerides may be due to the addition of L-arginine to the formula.